Atalanta Therapeutics
1 follower
‌
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing the proprietary RNA interference platform.
Industries
Headquarters
Employees
Links
Org chart
Alicia Secor
President & CEO
Alicia Secor
Collapse
Aimee L. Jackson
Chief Scientific Officer
Morgan Molloy
Chief Corporate Development Officer
Bart G. Newland
General Counsel
Maurice Smith
Senior Director & Controller
Michele Keough
SVP, Program & Alliance Management
Stephen Burke
SVP, Human Resources
Guillermo Yudowski
VP, Biochemistry & Pharmacology, In vitro Biology
Brittany Ferdman
Purchasing Coordinator
Anastasia Khvorova
Co-founder
Craig Mello
Co-founder
Jeff Young
Chief Financial Officer
Jim Glasheen
Co-founder
Serena Hung
Chief Medical Officer
Mark Murphy
Senior Facilities Manager
Matthew Grear
Lab Operations Manager
Antonio N.
Sr. Director Information Technology
